HIV Risk Assessment Prototype

Download Document:
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet icon

tl-18-19.xlsx — application/vnd.openxmlformats-officedocument.spreadsheetml.sheet, 73 kB (75,064 bytes)

Author(s): MEASURE Evaluation

Year: 2019

Abstract:

In this period of limited resources, there is a desire to reduce overall testing costs while strategically targeting for testing people most likely to be HIV-positive. The Office of the Global AIDS Coordinator recommends that an HIV Risk Assessment be applied to all children whose HIV status is unknown, to identify children at risk for HIV infection. MEASURE Evaluation developed an HIV Risk Assessment prototype that implementing partners may adapt to assess risk among orphans and vulnerable children. The prototype’s purpose is to improve the quality of data collected for reporting to the Data for Transparency and Impact (DATIM) system of the United States President’s Emergency Plan for AIDS Relief (PEPFAR).

This is the letter size version of the tool. Download the A4 size.

Filed under: Orphans and Vulnerable Children , Tools , OVC , HIV

TB DIAH will run until September 2023, PMI Measure Malaria until June 2024, and D4I until September 2023.

MEASURE Evaluation is funded by USAID to strengthen capacity in developing countries to gather, interpret, and use data to improve health. We create tools and approaches for rigorous evaluations, providing evidence to address health challenges. And we strengthen health information systems so countries can make better decisions and sustain good health outcomes over time.

MEASURE Evaluation
Carolina Population Center
University of North Carolina at Chapel Hill
123 W Franklin St
Chapel Hill, North Carolina 27516
Email: measure@unc.edu
www.measureevaluation.org

MEASURE Evaluation is funded by the United States Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The information provided on this web site is not official U.S. government information and does not necessarily represent the views of USAID, PEPFAR or the U.S. government.

HIV Risk Assessment Prototype

Personal tools